Next Article in Journal
Randomized Clinical Trial for the Optimization of Dyslipidemia Management in Patients with End-Stage Renal Disease Undergoing In-Hospital Maintenance Hemodialysis Therapy
Next Article in Special Issue
Membrane Vesicles as Drug Delivery Systems: MISEV, In Vivo Fluorescence Imaging and Tracking, Specific Tissue Targeting, and Therapeutic Application in Diseases
Previous Article in Journal
Developing In Vitro–In Vivo Correlation for Bicalutamide Immediate-Release Dosage Forms with the Biphasic In Vitro Dissolution Test
Previous Article in Special Issue
Minimal Information for Studies of Extracellular Vesicles (MISEV): Ten-Year Evolution (2014–2023)
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(9), 1127; https://doi.org/10.3390/pharmaceutics17091127
Action Date Notes Link
article html file updated 28 August 2025 18:29 CEST Original file https://www.mdpi.com/1999-4923/17/9/1127/html
article pdf uploaded. 28 August 2025 18:27 CEST Version of Record https://www.mdpi.com/1999-4923/17/9/1127/pdf
article xml uploaded. 28 August 2025 18:27 CEST Update https://www.mdpi.com/1999-4923/17/9/1127/xml
article xml file uploaded 28 August 2025 18:27 CEST Original file -
Back to TopTop